BSEInsider Trading / SAST22 Aug 2026 · 22 Aug 2026, 10:13 am
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 21, 2026 for Hemal V Mehta & Sachin V Mehta
Sudarshan Pharma Industries Ltd · 543828
✦ AI SummaryPledge
Sudarshan Pharma Industries Ltd has made a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of a pledge on the company's equity shares by persons belonging to the 'Promoter' category.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Attachments (1)
📄pdf
Download →
92CE3EFC_74FE_49A5_9949_41D22408AF63_101300.pdf
View document text
IUDIRXHIII PH[R]I[
IIIDUTTRTEX LID
Head Office : 301, Aura Biplex, Premium Hetail Premises, 7, S.V. Road, Borivali (West), hXumbai - 400092.
E-mail :compliance@sudarshanpharma.com.Website:www.sudarshanpharma.com
Board Line : +91 -22-422211 1 '1 I 43331 111 I 422211 16 (100 linel . 911,1 : 151496ti/H200BPLC1 B4gg7
s P r L/cs/s E/ 2026-2027 / s2 Date: 21't August, 2026
The Listing Department BSE Scrip Code: 543828
BSE Limited BSE Trading Symbol: SUDARSHAN
Phiroze Jeejeebhoy Towers, lSlN: lNE00TV01023
Dalal Street, Mumbai - 400 001
Sub lntimation as per Regulation 31(1) & 31(2) of SEBI (Substantial AcQuisition of Shares and
Takeovers) Regu lations, ?.OLL
With reference to the above cited subject, please find enclosed Disclosure as per the Regulation 31(2)
of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 201-1 in connection with
creation of Pledge on the equity shares of the Company by persons belonging to the "Promoter"
category.
Request you to tal<e the same on record.
For, Sudarshan Pharma lndustries Limited
rav Shah ri)
Company Secreta
Encl: As above
Regd. Otf. : 301, Aura Biplex, Above Kalyan Jewellers, $,V. Hoad, Borivali (\rVest), Mumbai - 400092.
oc)E o8C oofo \ r-l 3-
t sos-
s6 ;o 3EE s
E = (o
o :Po) N
E;1L
E c ()C O o
o q) C' .),5=* VoUo'
.# o
oq a oI -) *
Eo L (,+ rY a =^ :: .- a =_i o
zd AqL O ( co
N r- dEt 90) rO
o I=6qb qb> qrJ
b >* Y..o
oE I I FPE
E tb9rd E "ir=
ztul-o)
'C-or
(,N *- oriE s
o (U v !
L( oc(/D sE#==$ q o
-aCn.f,
'rN o O
" O= o) C (0 +o(/q)) O O^ =a
oo) og O .o
crr' -o o^ L
*L Q,,^
: ol
-L LA ( (o
Ea )
t :0 >) C o .0) c
( C o) lO <o o
E p o3 Zx 'E H c g i ;G K Eo E[i.o : (s(s( E Ls
OF,($ .E g (oD :L f (g r o-V - $-C =.= yJ trL
F>p 'C6 d0)fOi &**a =o_ =
-o E co & r<-
ou, = o 8; o;, -> -r ( 6 *(I .) a-c
cO) (Ey=
r aLo 0 o)L( )) a OE +_c J ,E Uo E) a C o
* Fo ( gc l)o O$ E dQ : c -9 o 0P v ( -,] 9 b .a Lo C ] Lo o oC) ) Tt os .Y OX f -o A
a rF =E
(Uc o -^UL J
F,9 E= a 0)vL
Ya C G ** o O
+L.-= (s
o0.) .lx=c@e"= frs:
OO E
-#C ,o)
sL #(s
Eg$$E
(tr.9 o_ io o
ot C Eo ( No 0o) o)
o Rr a(o .( C aE :E O N C (s --e
::r) L
@oI (s _L
o.< x o.Y .C
+Y aa E U:l
L U mU ) r NI -E o E f
Fq H -5'E E$ g o o
C C)
() a o =
--^Ya Lr uLn )J .C o q o- *- OE
L o o:.=
oo (g OE, z
_ ^* o c v^ c Cr rj
-0 L 0 7C) ) 1
.C a o a
0 U ( q o5) )) .- o c > U(e r'o l l" JR0 9 o-- Dt ob c^ Lc v\ s voAE o# g
vU La -) =)? :-5 O a -C (- ^r =u vr soo z.i(50L Z
o E- p- '^ = ECc (U') c L ( Ct) r O=r o : 0 ( oo 0) .o ( o o; g: .E * so- ( .PU eIU: -=O ;.l
6 s s
( N O No
d .CUJcD OE o L lX < oll (E o o Lo_ o C o o c C o . o _6 OL cO) r E ( o oO ^ = FN o.- , --GJ oo 3a )
_o a#o o o _ ao (s e3., + oa o N O E<
0 : a o) t( -6 - .C ( o6 E o L o o_ .( C o oE o Lo o oo - C 9( # -L oU 5t Zo AqL N r @ (O o = $N
o 0-) .C _c
.o9. Fo
- \FoC -( L os o
o.rg. g.C- o=
ls rLo
o E o E) ( !) 0) 0 E) E : of, '(E Ck = -'>^ v).5- 99= E oo r=.l
Z(U z -G
o(6 Z([ -
oo z_oo_ q I-
*- o6
o cO)c l Oc (r )co \--L OSEE >S
se53 (o
a-: P-or N
C 1. - :o()f * c.+ c * C O)
6'BoGEa o0()/) O.
";5 /i(U
ff 5s: c)-
:f E * e 4A (o
o) lo- o (/)=>-1 .- (o
;9p -(]
E i,6 ES
u l L:) ^Y th,== Q (,o a d N c, F = (/) . L= L J.=
C) Z6- 5! d)
c Lo
r^o =;r =1 36 o qv\ r oo
00r .=
-C ra E
+( Cfi 6--, q o -) O
' J' a-i
-:f (6 Fo(D0) O
C (: ) O) -L o .i O ,C
(Er*v" E aa a
-fr4 o flc
c :l>o C o . Xo o) +> t:
c ct co ) o tns I saE E eE ( Es
CLi -Y CgJ)
C OC
H .6: 6A qH &E EE :E (6<uL
(s:f t'(f) :
. tg
lcq. 't ,9
I &*
5O rLL
As ()ij)
gi El i Uo
3 -oQt coa
. '=-?
( tr- @c"
rLo tL r -[ C J a
c q) - Fo o o s 5o= ( f,.
: ;Ya #= ro o oc) E a(s LYh A:- Jo
{)+ 'i: () L
GO a f r+ o- I co ''o-l'l =-
F.9 C U)
c) '= C (s q)
** O
!.- (6 o
#o: rJ o IE$fis
-()< L (6
N r Eg$$E
c- *E
oS n o
() (o
C N Co) 0)
$)(u rTl C --e
Cia f) :C f{ $
x tJ) :O U (n I , - aC ( (c j s ! r o uq_ d. . )- c XP d.Y (u aX 3= O a. ! 3l
-*l II ''1 c ,vL-
iu) C) () rtos- *- O
_() r(F :) ^ o .L( C$ 0a) 9u(o9- (( D, bi5 so e#o (u 5a= .=rU Z
o oN v .L u C ( oJ U o a o) G c o) no C !
. r; -
- .Oo DL^ C -N s oU G)
- Va Q_C') = a .9. - 3C L ooP .i(IJL z
CiJ -
J.r6 ^
lG iC
C $ C
eJ) l) o !([ oC o
C ( ()
' .jC o
oU .
.-#$
O olu U
n-co h .=G
c d on
. .( E-
)3((
_o {) aO o E - (oo n $ o 0) o (n + o .iA (o tr f $ O-_ 5)-ar
-L =f ^i F
-( r)
"t Cr
.( C"}
.o o
C C)
( C) o o
oE o
so 0 :) Z-t N O I\ a ( $)i
t\ ' li- 2,
.n9. Z( ( E (J U) Zo U 0 E CS)' -o a 0 L ( ac0) t oos ( (s) zo 0 E (s) _( E f o
( oot a ( os 6 t Es P= u -9 j. P: Eu_ L>
c *? _?;E -- j ac 6: S >o.r